Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated sodium channels (Nav) are transmembrane proteins essential for the initiation and propagation of action potentials in neurons (Catterall, 2012, Journal of Physiology). The neuronal subtypes are categorized into those primarily in the central nervous system (Nav1.1, Nav1.2, Nav1.3, and Nav1.6) and those in the peripheral nervous system (Nav1.7, Nav1.8, and Nav1.9) (Dib-Hajj et al., 2013, Nature Reviews Neuroscience). These channels facilitate the rapid influx of sodium ions in response to membrane depolarization, a process vital for electrical signaling and neurotransmission. Mutations in the genes encoding these channels are linked to a spectrum of neurological disorders, including various forms of epilepsy and chronic pain conditions like inherited erythromelalgia (Meisler & Kearney, 2005, Journal of Clinical Investigation). Pharmacologically, these channels are targeted by anticonvulsants and local anesthetics that bind to the pore-forming alpha subunit to stabilize the inactivated state, thereby reducing neuronal hyperexcitability (StatPearls, 2023, Physiology, Sodium Channels). Current drug development efforts are focused on achieving subtype selectivity, particularly for Nav1.7 and Nav1.8, to provide effective analgesia without the central or cardiac side effects associated with non-selective sodium channel blockers (Baguet et al., 2020, Expert Opinion on Therapeutic Targets).
Inhibition of sodium ion influx by binding to the alpha-subunit, typically stabilizing the inactivated state of the channel to prevent repetitive firing (Catterall, 2012, Journal of Physiology; StatPearls, 2023).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-gated sodium channel, neuronal subtype (Nav).